_version_ 1783524016265363456
author Hayakawa, Michiyo
Umeyama, Hideaki
Iwadate, Mitsuo
Taguchi, Y.-H.
Yano, Yoshihiko
Honda, Takashi
Itami-Matsumoto, Saori
Kozuka, Ritsuzo
Enomoto, Masaru
Tamori, Akihiro
Kawada, Norifumi
Murakami, Yoshiki
author_facet Hayakawa, Michiyo
Umeyama, Hideaki
Iwadate, Mitsuo
Taguchi, Y.-H.
Yano, Yoshihiko
Honda, Takashi
Itami-Matsumoto, Saori
Kozuka, Ritsuzo
Enomoto, Masaru
Tamori, Akihiro
Kawada, Norifumi
Murakami, Yoshiki
author_sort Hayakawa, Michiyo
collection PubMed
description
format Online
Article
Text
id pubmed-7171149
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-71711492020-04-24 Author Correction: Development of a novel anti-hepatitis B virus agent via Sp1 Hayakawa, Michiyo Umeyama, Hideaki Iwadate, Mitsuo Taguchi, Y.-H. Yano, Yoshihiko Honda, Takashi Itami-Matsumoto, Saori Kozuka, Ritsuzo Enomoto, Masaru Tamori, Akihiro Kawada, Norifumi Murakami, Yoshiki Sci Rep Author Correction Nature Publishing Group UK 2020-04-21 /pmc/articles/PMC7171149/ /pubmed/32313085 http://dx.doi.org/10.1038/s41598-020-63866-z Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Author Correction
Hayakawa, Michiyo
Umeyama, Hideaki
Iwadate, Mitsuo
Taguchi, Y.-H.
Yano, Yoshihiko
Honda, Takashi
Itami-Matsumoto, Saori
Kozuka, Ritsuzo
Enomoto, Masaru
Tamori, Akihiro
Kawada, Norifumi
Murakami, Yoshiki
Author Correction: Development of a novel anti-hepatitis B virus agent via Sp1
title Author Correction: Development of a novel anti-hepatitis B virus agent via Sp1
title_full Author Correction: Development of a novel anti-hepatitis B virus agent via Sp1
title_fullStr Author Correction: Development of a novel anti-hepatitis B virus agent via Sp1
title_full_unstemmed Author Correction: Development of a novel anti-hepatitis B virus agent via Sp1
title_short Author Correction: Development of a novel anti-hepatitis B virus agent via Sp1
title_sort author correction: development of a novel anti-hepatitis b virus agent via sp1
topic Author Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171149/
https://www.ncbi.nlm.nih.gov/pubmed/32313085
http://dx.doi.org/10.1038/s41598-020-63866-z
work_keys_str_mv AT hayakawamichiyo authorcorrectiondevelopmentofanovelantihepatitisbvirusagentviasp1
AT umeyamahideaki authorcorrectiondevelopmentofanovelantihepatitisbvirusagentviasp1
AT iwadatemitsuo authorcorrectiondevelopmentofanovelantihepatitisbvirusagentviasp1
AT taguchiyh authorcorrectiondevelopmentofanovelantihepatitisbvirusagentviasp1
AT yanoyoshihiko authorcorrectiondevelopmentofanovelantihepatitisbvirusagentviasp1
AT hondatakashi authorcorrectiondevelopmentofanovelantihepatitisbvirusagentviasp1
AT itamimatsumotosaori authorcorrectiondevelopmentofanovelantihepatitisbvirusagentviasp1
AT kozukaritsuzo authorcorrectiondevelopmentofanovelantihepatitisbvirusagentviasp1
AT enomotomasaru authorcorrectiondevelopmentofanovelantihepatitisbvirusagentviasp1
AT tamoriakihiro authorcorrectiondevelopmentofanovelantihepatitisbvirusagentviasp1
AT kawadanorifumi authorcorrectiondevelopmentofanovelantihepatitisbvirusagentviasp1
AT murakamiyoshiki authorcorrectiondevelopmentofanovelantihepatitisbvirusagentviasp1